Company Profiles

driven by the PitchBook Platform

Agilvax

Description

Developer of cancer immunotherapies and targeted vaccines designed to treat cancer and infectious diseases. The company's cancer immunotherapies and targeted vaccines are able to rapidly identify and select lead immunotherapy candidates through the power of the body's own immune system in combination with proprietary Virus Like Particle (VLP) platform technology, enabling physicians to treat aggressive forms of breast cancer, targeting breast cancer stem cells.

2011

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$286k

Latest Deal Amount

$3.7M

Total Amount Raised

Description

Developer of cancer immunotherapies and targeted vaccines designed to treat cancer and infectious diseases. The company's cancer immunotherapies and targeted vaccines are able to rapidly identify and select lead immunotherapy candidates through the power of the body's own immune system in combination with proprietary Virus Like Particle (VLP) platform technology, enabling physicians to treat aggressive forms of breast cancer, targeting breast cancer stem cells.

Website:

www.agilvax.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

5901 Indian School Road NorthEast Albuquerque, NM 87110United States +1 (505) 200-9541
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Agilvax's full profile, request a free trial.

    Agilvax Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Agilvax Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Agilvax Investors (5)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BioScience CenterAccelerator/IncubatorMinority000 0000000 0000
    Hunt CompaniesReal EstateMinority000 0000000 0000
    National Institute Of Allergy and Infectious Diseases Extramural ActivitesGovernment000 0000000 0000
    Southwest Medical VenturesVenture CapitalMinority000 0000000 0000
    Sun Mountain CapitalPE/BuyoutMinority000 0000000 0000
    BioScience Center Accelerator/Incubator
    Hunt Companies Real Estate
    National Institute Of Allergy and Infectious Diseases Extramural Activites Government
    Southwest Medical Ventures Venture Capital
    Sun Mountain Capital PE/Buyout

    Agilvax Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Michael PerrineDirector, Business Development
    Les StewartExecutive
    Federica Pericle Ph.DChief Executive Officer, President and Board Member
    Dee BresciaChief Financial Officer
    Constance DorianDirector, Technical Operations
    Michael Perrine Director, Business Development
    Les Stewart Executive
    Federica Pericle Ph.D Chief Executive Officer, President and Board Member
    Dee Brescia Chief Financial Officer
    Constance Dorian Director, Technical Operations

    Agilvax Board Members (7)

    NameRepresentingRoleSinceContact
    Info
    Brad Vale Ph.DSelfBoard Member000 0000
    Brian BirkSun Mountain CapitalCo-Founder & Managing Partner000 0000
    Ebetuel Pallares Ph.DJoseph Advisory ServicesFounder, Chief Executive Officer & President000 0000
    Faith Charles JDSelfBoard Member000 0000
    Stuart Rose Ph.DSelfBoard Member000 0000
    Brad Vale Ph.D Board Member Self
    Brian Birk Co-Founder & Managing Partner Sun Mountain Capital
    Ebetuel Pallares Ph.D Founder, Chief Executive Officer & President Joseph Advisory Services
    Faith Charles JD Board Member Self
    Stuart Rose Ph.D Board Member Self
    Request full access to PitchBook